Pharma & Biotech Litigation Summit North America

Join us at The Pharma & Biotech Patent Litigation Summit North America 2026, taking place in Boston on 15-16 September, where leading in-house counsel, patent litigators and IP professionals will come together to develop, define and innovate effective patent litigation strategies.

As patent disputes become increasingly complex, high-value and cross-border, this industry-led event provides critical insights into the legal, scientific and regulatory developments shaping the life sciences sector. Discussions will explore the most pressing issues facing pharmaceutical and biotechnology companies today, including biosimilars, litigation, patent portfolio risk management, regulatory exclusivities, emerging therapeutics and global enforcement strategies.

Bringing together senior decision-makers from innovative pharma, biotech, generics and biosimilars companies, alongside leading private practice attorneys, regulators and judges, the summit offers a unique platform to examine the latest litigation trends across the US and beyond.

The event also includes access to the UPC Litigation Forum, taking place on 14 September, which brings together top in-house counsel, private practice litigators, regulators and members of the judiciary to discuss the latest procedural developments, strategic considerations and key decisions emerging from the Unified Patent Court.
Included in your ticket.

With a distinguished faculty featuring leading patent litigators, senior IP counsel and judicial representatives, including Klaus Grabinski, President of the UPC Court of Appeal, attendees will gain valuable perspectives from those shaping the future of patent litigation globally.

In addition, we are delighted to have our own specialists participating in key sessions. Partner and Co-Head of Litigation in Canada, Kamleh Nicola, will chair an industry-led panel session ‘Litigation Readiness for Aquired Products' and Partner Mike Gilbert (UK) and Partner Dan McGrath (UK), will host two roundtables covering the topic ‘How is AI driving behaviours in the life science sector and how is this impacting patents and patent litigation strategy’.

Join the team - Nick McDonald; Mike Gilbert; Dan McGrath; Kamleh Nicola for an in-depth exploration in pharma and biotech patent litigation. This event connects you with industry leaders and innovators actively shaping the landscape. Network with key players and gain insights to stay ahead of the curve.